These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32879081)

  • 1. Valproic acid concentration and biochemical indexes in epilepsy outpatients during monotherapy or combination therapy.
    Yang X; Wang P; Pan J; Wang C; Luo J; Ma H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):782-789. PubMed ID: 32879081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of valproic acid and 2-propyl-4-pentenoic acid concentrations with adverse reaction in 254 Chinese patients with epilepsy.
    Ma H; Zhu W; Wang C; Pan J; Yang X; Luo J; Wang P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):775-783. PubMed ID: 31413215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
    Gidal BE; Pitterle ME; Spencer NW; Maly MM
    J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with blood carnitine levels in adult epilepsy patients with chronic valproic acid therapy.
    Saito M; Takizawa T; Miyaoka H
    Epilepsy Res; 2021 Sep; 175():106697. PubMed ID: 34175794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
    Tseng YL; Huang CR; Lin CH; Lu YT; Lu CH; Chen NC; Chang CC; Chang WN; Chuang YC
    Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy.
    Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M
    Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing pharmacokinetics-pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients.
    Prawira Nata Nugraha IK; Purnamayanti A; Ngurah Made Suwarba IG; Parfati N
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):305-311. PubMed ID: 34214324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy].
    Sołowiej E; Sobaniec W
    Neurol Neurochir Pol; 2003; 37(5):991-1003. PubMed ID: 15174247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum concentration and dose of valproic acid during monotherapy in adult outpatients.
    Tisdale JE; Tsuyuki RT; Oles KS; Penry JK
    Ther Drug Monit; 1992 Oct; 14(5):416-23. PubMed ID: 1448851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS; Srinivas R; Sadhotra A
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
    Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
    Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.